Introduction
In today’s rapidly evolving biotechnology and pharmaceutical landscape, High-Throughput Screening (HTS) has emerged as a game-changing technology. It enables scientists to rapidly test thousands to millions of chemical, genetic, or pharmacological samples for biological activity. The demand for HTS is growing exponentially, driven by advances in automation, artificial intelligence (AI), and the increasing need for precision medicine.
